Cost-effectiveness of screening for bowel cancer: Increasing bowel cancer testing rates through a general practitioner-organised health care package would reduce incidence and prove cost-effective

Medical Journal of Australia

Volumn 204, Issue 1, 2016, Pages 11-12.e1

  Bolin, Terry D ^a   Korman, Melvyn G ^b   Nicholson, Fiona ^b   Pezzullo, Lynne ^c   Engelman, Jeffrey ^d   Collings, Katherine ^e   Creelman, David Gilchrist ^c  

^a Gastrointestinal and Liver Clinic   (Australia)

^b SOUTHERN HEALTH   (Australia)

^c Deloitte Access Economics   (Australia)

^d St George Private Hospital   (Australia)

^e Gut Foundation   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AGING; ARTICLE; CANCER INCIDENCE; CANCER PREVENTION; CANCER SCREENING; CANCER TEST; COLONOSCOPY; COST EFFECTIVENESS ANALYSIS; GENERAL PRACTITIONER; HEALTH CARE COST; HUMAN; INTESTINE CANCER; OCCULT BLOOD TEST; ADULT; AGED; COST BENEFIT ANALYSIS; EARLY CANCER DIAGNOSIS; ECONOMICS; INTESTINAL NEOPLASMS; MIDDLE AGED;

ADULT; AGED; COLONOSCOPY; COST-BENEFIT ANALYSIS; EARLY DETECTION OF CANCER; HUMANS; INTESTINAL NEOPLASMS; MIDDLE AGED;

EID: 84973410661     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/mja15.00037     Document Type: Article

References (10)

1. O’Leary B, Olynyk J, Neville M, Platell C. Cost effectiveness of colorectal cancer screening: comparison of community-based flexible sigmoidoscopy with fecal occult blood testing and colonoscopy. J Gastroenterol Hepatol 2004; 19: 38-47.
2. Cenin DR, St John DJ, Ledger MJ, et al. Optimising the expansion of the National Bowel Cancer Screening Program. Med J Aust 2014; 201: 456-461. https://www.mja.com.au/journal/2014/201/8/optimising-expansion-national-bowelcancer-screening-program
3. KPMG. Review of the National Bowel Cancer Screening Program (Phase 2): Final report, part one. Canberra: Department of Health and Ageing, 2012. http://cancerscreening.gov.au/internet/screening/publishing.nsf/Content/C1EED399C650C2F3CA257D8D001F10E9/$File/review-nbcsp-fr-p1.pdf (accessed Apr 2015).
4. Australian Institute of Health and Welfare. Australian cancer incidence and mortality book for colorectal cancer. Canberra: AIHW, 2015.
5. Young JP, Win AK, Rosty C, et al. Rising incidence of earlyonset colorectal cancer in Australia over two decades: report and review. J Gastroenterol Hepatol 2015; 30: 6-13.
6. Australian Bureau of Statistics. Household income and income distribution, Australia, 2011-12. Canberra: ABS, 2013. (ABS Cat. No. 6523.0.) http://www.abs.gov.au/AUSSTATS/abs@.nsf/DetailsPage/6523.02011-12?OpenDocument (accessed Apr 2015).
7. Deloitte Access Economics. Cost-effectiveness of screening for bowel cancer. Canberra: The Gut Foundation, 2011. http://www2.deloitte.com/au/en/pages/economics/articles/costeffectiveness-screening-for-bowel-cancer.html (accessed Apr 2015).
8. Viiala CH, Zimmerman M, Cullen DJ, Hoffman NE. Complication rates of colonoscopy in an Australian teaching hospital environment. Intern Med J 2003; 33: 355-359.
9. Tan-Torres Edejer T, Baltussen R, Adam T, et al, editors. Making choices in health: WHO guide to cost-effectiveness analysis. Geneva: World Health Organization, 2003. http://www.who.int/choice/publications/p_2003_generalised_cea.pdf (accessed Apr 2015).
10. Bolin T, Benstock S, Fernon V, et al, editors. Further evidence to lower the recommended screening age for colorectal cancer. Paper presented at: 78th Annual Meeting of the American College of Gastroenterology; 2013 Oct 11-16; San Diego, USA. A summary of the study’s purpose, methods, results and conclusions is available at http://www.nature.com/ajg/journal/v108/n1s/pdf/ajg2013273a.pdf?WT.ec_id=AJG-201310 (accessed Aug 2015).